|
Market Closed -
Nasdaq
16:00:00 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 18.42 USD | +4.96% |
|
+4.63% | +5.32% |
| 09-09 | Summit Therapeutics Shares Rise After Upgrade From Jefferies | MT |
| 09-09 | Jefferies Upgrades Summit Therapeutics to Buy From Hold, Adjusts Price Target to $25 From $15 | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 21.57 | +66.2% | 13 | ||||||
| 187.07 | +23.69% | 18 | ||||||
| 1,170.7 | +18.14% | 15 | ||||||
| 200.18 | +54.69% | 22 | ||||||
| 49.74 | +23.66% | 24 | ||||||
| 102.47 | +23.2% | 20 | ||||||
| 2,453.79 | +17.29% | 15 | ||||||
| 1,397.26 | +9.16% | 8 | ||||||
| 618.43 | +32.94% | 18 | ||||||
| 53.69 | -4.33% | 16 | ||||||
| 678.06 | +26.86% | 16 | ||||||
| 110 | +32.77% | 12 | ||||||
| 134.65 | +74.32% | 21 | ||||||
| 109.9 | +48.98% | 20 | ||||||
| 109 | +83.29% | 9 | ||||||
| 12.75 | +61.19% | 4 | ||||||
| 100.18 | +58.52% | 16 | ||||||
| 120.08 | +32.54% | 13 | ||||||
| 228.89 | +31.7% | 9 | ||||||
| Average | 413.6 | +37.62% | 15 | ||||||
| Weighted average by Cap. | 519.58 | +30.94% | 16 |
- Stock Market
- Stocks
- SMMT Stock
- Sector Summit Therapeutics Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
